secwatch.observer — SEC 8-K summary
======================================

Issuer:     NATIONAL HEALTH INVESTORS INC (NHI)
CIK:        0000877860
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0000877860-23-000016
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NHI Q4 net income $0.04/diluted share; new $160M buyback; 2023 FFO guidance $4.24-$4.30
--------------------------------------------------------------------------------

- Q4 2022 net income $0.04/diluted share vs $0.14 YoY; full year $1.48 vs $2.44.
- NAREIT FFO per diluted share Q4 $0.74 vs $1.07; full year $3.55 vs $4.62.
- Q4 loan and realty losses $22.0M including $8.7M credit loss reserve and $13.3M impairments.
- New $160M stock repurchase plan replaces $240M plan; 2.5M shares repurchased at avg $61.56 in 2022.
- 2023 guidance: NAREIT FFO per diluted share $4.24-$4.30; Normalized FAD $185.3-$187.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/877860/000087786023000016/0000877860-23-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/877860/000087786023000016/nhi-20230221.htm
  HTML page:      https://secwatch.observer/filing/0000877860-23-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer